Philippine FDA Warns Public Against Unregistered Mounjaro Product

The Philippine Food and Drug Administration (FDA) has issued a public health warning regarding the purchase and use of an illegally diverted and unregistered version of Mounjaro 2.5 mg/ 0.5 mL Subcutaneous Injection. The agency advises against distributing this unauthorized drug, stating that regulatory actions will be taken against violators. This aims to protect public safety from potentially unsafe or ineffective products.